NextCure Shares Fall 26% After Halting Development of One Drug Candidate

By Will Feuer Shares of NextCure lost about a quarter of their value after the biopharma company said it will halt the development of its NC762 drug...

Related Keywords

Legochem Biosciences , ,Will Feuer ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Financial Performance ,Share Price Movement Disruptions ,Corporate Industrial News ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Nextcure ,Nxtc ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Commodity ,Financial Market News ,Healthcare ,Life Sciences ,